Loading insider details...
Latest Form 4 (Nov 20, 2024): Sale of 36,133 SYRS shares, $7.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 20, 2024 | Syros Pharmaceuticals, Inc. (SYRS) | Sale | 36,133 | $7.9K |
| Nov 4, 2024 | Syros Pharmaceuticals, Inc. (SYRS) | Exercise/Conversion | 17,000 | n/a |
| Apr 2, 2024 | Syros Pharmaceuticals, Inc. (SYRS) | Exercise/Conversion | 2,000 | n/a |
| Nov 2, 2023 | Syros Pharmaceuticals, Inc. (SYRS) | Exercise/Conversion | 17,000 | n/a |
| Apr 4, 2023 | Syros Pharmaceuticals, Inc. (SYRS) | Exercise/Conversion | 2,000 | n/a |
| Feb 21, 2023 | Syros Pharmaceuticals, Inc. (SYRS) | Grant/Award | 35,000 | n/a |
| Oct 11, 2022 | Syros Pharmaceuticals, Inc. (SYRS) | Grant/Award | 44,500 | n/a |
| Apr 4, 2022 | Syros Pharmaceuticals, Inc. (SYRS) | Tax Withholding | 14,115 | $15.8K |
| Feb 17, 2022 | Syros Pharmaceuticals, Inc. (SYRS) | Grant/Award | 100,000 | n/a |